ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,262.08
1.38%
Dow Jones
44,296.51
0.97%
Gold vs US Dollar
2,715.28
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,814.71
-0.22%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Anixa Biosciences Inc (ANIX)

  7. Anixa Biosciences Inc (ANIX) News

Anixa Biosciences (ANIX)

Anixa Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANIX
DateTimeSourceHeadlineSymbolCompany
22/11/202413:15PR Newswire (US)Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve AssetNASDAQ:ANIXAnixa Biosciences Inc
18/11/202413:20PR Newswire (US)Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
08/11/202418:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIXAnixa Biosciences Inc
08/11/202418:17PR Newswire (US)Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:ANIXAnixa Biosciences Inc
06/11/202413:30PR Newswire (US)Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:ANIXAnixa Biosciences Inc
31/10/202412:15PR Newswire (US)Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024NASDAQ:ANIXAnixa Biosciences Inc
28/10/202412:30PR Newswire (US)Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:ANIXAnixa Biosciences Inc
23/10/202415:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
15/10/202413:00PR Newswire (US)Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
07/10/202412:30PR Newswire (US)Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical DevelopmentNASDAQ:ANIXAnixa Biosciences Inc
30/09/202412:30PR Newswire (US)Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T TrialNASDAQ:ANIXAnixa Biosciences Inc
24/09/202412:30PR Newswire (US)Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer VaccineNASDAQ:ANIXAnixa Biosciences Inc
18/09/202412:30PR Newswire (US)Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer ConferenceNASDAQ:ANIXAnixa Biosciences Inc
06/09/202421:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIXAnixa Biosciences Inc
03/09/202412:30PR Newswire (US)Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research SymposiumNASDAQ:ANIXAnixa Biosciences Inc
26/08/202412:30PR Newswire (US)Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:ANIXAnixa Biosciences Inc
01/08/202416:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
29/07/202412:45PR Newswire (US)Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual MeetingNASDAQ:ANIXAnixa Biosciences Inc
29/07/202410:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
26/07/202417:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
23/07/202412:15PR Newswire (US)Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T TherapyNASDAQ:ANIXAnixa Biosciences Inc
17/07/202412:00PR Newswire (US)Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine TechnologyNASDAQ:ANIXAnixa Biosciences Inc
15/07/202412:30PR Newswire (US)Anixa Biosciences Announces $5 Million Share Repurchase ProgramNASDAQ:ANIXAnixa Biosciences Inc
24/06/202412:45PR Newswire (US)Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical TrialNASDAQ:ANIXAnixa Biosciences Inc
18/06/202413:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
14/06/202413:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
12/06/202415:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
10/06/202414:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
07/06/202416:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
07/06/202414:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIXAnixa Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ANIX

Your Recent History

LSE
POS
Plexus
LSE
VAST
Vast Resources
LSE
CPI
Capita
LSE
TPL
Tethys
LSE
DEC
Diversified Energy
LSE
GOLD
LSE
ITV
Itv
LSE
NESF
Nextenergy Solar
LSE
TSLA
1x Tsla
NASDAQ
SMCI
Super Micro Computer
LSE
MIN
Minoan
LSE
SRSP
Sirius Petroleum
LSE
SYME
Supply@me Capital
LSE
GGP
Greatland Gold
LSE
SCLP
Scancell
LSE
OCDO
Ocado
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06